ArticleMethods in molecular biology (Clifton, N.J.)2026
Oocyte and Embryo Vitrification.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Widespread use of oocyte cryopreservation began after the introduction of vitrification, allowing women to postpone childbearing, precipitated by age-related declines in fertility. Similarly, vitrification offers poor responder patients the option of accumulating embryos. Over the last decade, several advances in vitrification technologies have improved clinical efficiency and outcome, reduced the dependence on operator skills, and raised success rates to higher and more uniform levels. As a result, vitrification has become reliable and safe, completely replacing slow cooling as the method of choice. Minimum volume methods, in particular the advanced Cryotec Ready to Use (RtU) system, as described here, ensure achieving the highest viability in oocytes and embryos at any stage can be achieved safely. A robust vitrification protocol is therefore a cornerstone of any ART program.
Indexed as
Identifiers
42681381What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.